Application of deubiquitinating enzyme USP28 in preparation of medicine for preventing or treating pancreatic cancer
A technology for deubiquitinating enzymes and pancreatic cancer, which can be used in drug combinations, biochemical equipment and methods, enzymes, etc., and can solve the problems of unclear biological functions and expression patterns of pancreatic cancer.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] Materials and Method
[0040] Patient and tumor specimens
[0041] Matching pancreatic cancer and normal pancreatic tissue were taken from 102 cases of pancreatic cancer patients in General Surgery of the Second Affiliated Hospital of Nanchang University in 2015-2019. The removal specimen immediately placed in liquid nitrogen, and stored at -80 ° C for further analysis. All patients have gained written informed consent, and the research procedures were approved by the Ethics and Research Committee of the Second Affiliated Hospital of Nanchang University. Table 1 summarizes the clinical features of all patients.
[0042] Cell line and cell culture
[0043] The normal pancreatic catheter epithelial cell line (H6C7 was used as a control) and a pancreatic cancer cell line (ASPC-1, PANC-1, BXPC-3 and SW1990) purchased from the American Typical Casting Center (Virginia, Virginia, USA). The cell line was cultured under the addition of 10% fetal bovine serum and 100 units / ml peni...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com